Vx-006

N/A

Report date: 2025/02/06 10:15:53

Base Information

Drug NameVx-006

Drug Alias NameVx-006

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionTelomerase reverse transcriptase inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonistsMelanoma-specific antigens inhibitors

TargetsTelomerase reverse transcriptaseReceptor protein-tyrosine kinase erbB-2Melanoma-specific antigens

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGreece

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVaxon Biotech

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaxon Biotech

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A